It's too easy for drug companies to skirt lax academic regulations
(Newser) -
Weak legislation allows professors to collect huge under-the-table payments from Big Pharma, and it’s time to fight back, Dan Greenberg writes in the
Chronicle of Higher Education. Pharmaceutical companies pay professors to shill drugs and lend their names to industry research, and the only oversight is an honor-system mechanism...
More »